Pterostilbene, a
stilbene phytoalexin, is mainly obtained
from
blueberries and grape vines; however, its metabolic mechanisms were
unclear in vivo. In the present study, three different methods were
used to prepare biological samples, and then, an efficient strategy
based on ultrahigh-performance liquid chromatography coupled with
mass spectrometry was developed to screen and identify pterostilbene
metabolites in rat urine, plasma, liver, and feces. In order to elucidate
pterostilbene or its metabolites involved in vitro, this study was
assessed by the liver microsome system. As a result, a total of 88
pterostilbene metabolites were characterized. Among them, 77 metabolites
in vivo and 14 metabolites in vitro were found; 50 and 38 metabolites
were observed in rat plasma and urine, while only 4 and 12 metabolites
were detected in rat feces and liver, inferring that plasma and urine
possessed more diverse types of pterostilbene metabolites; 41 metabolic
products were obtained by solid-phase extraction, and 9 and 10 metabolites
were screened by methanol precipitation and acetonitrile precipitation,
respectively, indicating that solid-phase extraction could be adopted
as the most acceptable method for pterostilbene metabolism. The results
also demonstrated that pterostilbene mainly underwent glucosylation,
dehydrogenation, hydrogenation, demethoxylation, sulfation, NAC binding,
methylene ketogenic, acetylation, and methylation. In summary, this
research provides an idea for the further study of drug metabolism.